Published in Gene Therapy Weekly, December 4th, 1995
The ten-patient study is the first reported human clinical trial for a cell-containing implant to deliver a recombinant protein within the central nervous system (CNS). Aebischer's study demonstrated the successful delivery of targeted levels of ciliary neurotrophic factor (CNTF), a growth factor under investigation to treat ALS. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.